STD - 1580 - New Chemical Assessment - 21 June 2016
STD - 1580 - New Chemical Assessment - 21 June 2016
July 2016
PUBLIC REPORT
This Assessment has been compiled in accordance with the provisions of the Industrial Chemicals (Notification
and Assessment) Act 1989 (the Act) and Regulations. This legislation is an Act of the Commonwealth of
Australia. The National Industrial Chemicals Notification and Assessment Scheme (NICNAS) is administered
by the Department of Health, and conducts the risk assessment for public health and occupational health and
safety. The assessment of environmental risk is conducted by the Department of the Environment.
This Public Report is available for viewing and downloading from the NICNAS website or available on request,
free of charge, by contacting NICNAS. For requests and enquiries please contact the NICNAS Administration
Coordinator at:
Street Address: Level 7, 260 Elizabeth Street, SURRY HILLS NSW 2010, AUSTRALIA.
Postal Address: GPO Box 58, SYDNEY NSW 2001, AUSTRALIA.
TEL: + 61 2 8577 8800
FAX: + 61 2 8577 8888
Website: www.nicnas.gov.au
Director
NICNAS
TABLE OF CONTENTS
SUMMARY ............................................................................................................................................................ 3
CONCLUSIONS AND REGULATORY OBLIGATIONS ................................................................................... 3
ASSESSMENT DETAILS ..................................................................................................................................... 5
1. APPLICANT AND NOTIFICATION DETAILS .................................................................................... 5
2. IDENTITY OF CHEMICAL .................................................................................................................... 5
3. COMPOSITION ....................................................................................................................................... 5
4. PHYSICAL AND CHEMICAL PROPERTIES ....................................................................................... 5
5. INTRODUCTION AND USE INFORMATION ..................................................................................... 6
6. HUMAN HEALTH IMPLICATIONS ..................................................................................................... 7
6.1. Exposure Assessment ...................................................................................................................... 7
6.1.1. Occupational Exposure ............................................................................................................... 7
6.1.2. Public Exposure .......................................................................................................................... 7
6.2. Human Health Effects Assessment ................................................................................................. 8
6.3. Human Health Risk Characterisation .............................................................................................. 9
6.3.1. Occupational Health and Safety ................................................................................................. 9
6.3.2. Public Health ............................................................................................................................ 10
7. ENVIRONMENTAL IMPLICATIONS ................................................................................................. 10
7.1. Environmental Exposure & Fate Assessment ............................................................................... 10
7.1.1. Environmental Exposure .......................................................................................................... 10
7.1.2. Environmental Fate .................................................................................................................. 11
7.1.3. Predicted Environmental Concentration (PEC) ........................................................................ 11
7.2. Environmental Effects Assessment ............................................................................................... 11
7.2.1. Predicted No-Effect Concentration .......................................................................................... 12
7.3. Environmental Risk Assessment ................................................................................................... 12
APPENDIX B: TOXICOLOGICAL INVESTIGATIONS ................................................................................................... 13
B.1. Acute toxicity – oral ...................................................................................................................... 13
B.2. Irritation – eye (in vitro) ................................................................................................................ 13
B.3. Skin sensitisation – human volunteers .......................................................................................... 14
B.4. Genotoxicity – bacteria ................................................................................................................. 14
APPENDIX C: ENVIRONMENTAL FATE AND ECOTOXICOLOGICAL INVESTIGATIONS ............................................... 16
C.1. Environmental Fate ....................................................................................................................... 16
C.1.1. Ready biodegradability............................................................................................................. 16
C.1.2. Anaerobic biodegradability ...................................................................................................... 16
C.2. Ecotoxicological Investigations .................................................................................................... 17
C.2.1. Algal growth inhibition test ...................................................................................................... 17
BIBLIOGRAPHY ................................................................................................................................................. 18
July 2016 NICNAS
SUMMARY
The environmental hazard classification according to the Globally Harmonised System of Classification and
Labelling of Chemicals (GHS) is presented below. Environmental classification under the GHS is not mandated
in Australia and carries no legal status but is presented for information purposes.
When used in the proposed manner, the notified polymer is not considered to pose an unreasonable risk to
public health.
Recommendations
CONTROL MEASURES
• No specific engineering controls, work practices or personal protective equipment are required for the
safe use of the notified polymer itself. However, these should be selected on the basis of all ingredients
in the formulation.
Guidance in the selection of personal protective equipment can be obtained from Australian,
Australian/New Zealand or other approved standards.
• If products and mixtures containing the notified polymer are classified as hazardous to health in
accordance with the Globally Harmonised System for the Classification and Labelling of Chemicals
(GHS) as adopted for industrial chemicals in Australia, workplace practices and control procedures
consistent with provisions of State and Territory hazardous substances legislation should be in
operation.
Public Health
• Product formulators should exercise due care when using the notified polymer in cosmetic products
given its potential ability to enhance the dermal penetration of other chemicals in the formulation.
Disposal
• Where reuse or recycling are not appropriate, dispose of the notified polymer in an environmentally
sound manner in accordance with relevant Commonwealth, state, territory and local government
legislation.
Emergency procedures
• Spills or accidental release of the notified polymer should be handled by containment, physical
collection and subsequent safe disposal.
Regulatory Obligations
Secondary Notification
This risk assessment is based on the information available at the time of notification. The Director may call for
the reassessment of the chemical under secondary notification provisions based on changes in certain
circumstances. Under Section 64 of the Industrial Chemicals (Notification and Assessment) Act (1989) the
notifier, as well as any other importer or manufacturer of the notified chemical, have post-assessment regulatory
obligations to notify NICNAS when any of these circumstances change. These obligations apply even when the
notified polymer is listed on the Australian Inventory of Chemical Substances (AICS).
Therefore, the Director of NICNAS must be notified in writing within 28 days by the notifier, other importer or
manufacturer:
The Director will then decide whether a reassessment (i.e. a secondary notification and assessment) is required.
ASSESSMENT DETAILS
1. APPLICANT AND NOTIFICATION DETAILS
APPLICANT
BASF Australia Ltd (ABN: 62 008 437 867)
Level 12, 28 Freshwater Place
SOUTHBANK VIC 3006
NOTIFICATION CATEGORY
Standard: Synthetic polymer with Mn < 1,000 Da (more than 1 tonne per year).
2. IDENTITY OF CHEMICAL
MARKETING NAME(S)
Plantapon LC7 (containing the notified polymer at ≤ 85% concentration)
Uvinul Easy (imported product containing the notified polymer at < 10% concentration)
CAS NUMBER
565429-75-6
CHEMICAL NAME
Poly(oxy-1,2-ethanediyl), α-hydro-ω-hydroxy-, mono(dihydrogen 2-hydroxy-1,2,3-propanetricarboxylate),
C12-18-alkyl ethers
OTHER NAMES
Laureth-7 Citrate (INCI name)
Citric acid, ester with alcohols C12-18, ethoxylated
Citric acid ester of ethoxylated fatty alcohol
Citric (FAEO C12-18 + 7EO)monoE
MOLECULAR WEIGHT
Number Average Molecular Weight (Mn) > 500 Da
ANALYTICAL DATA
Reference GPC and MALDI-MS spectra were provided.
3. COMPOSITION
DEGREE OF PURITY
> 80%
Reactivity
The notified polymer is expected to be stable under normal conditions of use.
Year 1 2 3 4 5
Tonnes <1 1-2 1-2 1-2 1-2
PORT OF ENTRY
Melbourne
USE
The notified polymer will be used as an emulsifier in cosmetic products at < 5% concentration.
OPERATION DESCRIPTION
The notified polymer will be imported as a component of a formulation (Uvinul Easy) at < 10% concentration
for reformulation into finished cosmetic products, or as a component of finished cosmetic products at < 5%
concentration, which will be sold to the public in the same form in which they are imported.
Reformulation
The procedures for incorporating the formulation Uvinal Easy containing the notified polymer at < 10%
concentration into end-use products will vary depending on the nature of the cosmetic product being formulated,
and both manual and automated steps will likely be involved. However, in general it is expected that the
reformulation processes will involve mixing and blending operations that will be highly automated and occur in
a fully enclosed systems with good ventilation, followed by filling of the reformulated products into containers
of various sizes (50 to 200 mL glass containers or plastic pump packs).
End-use
The finished cosmetic products containing the notified polymer at < 5% concentration will be used by consumers
and professionals (such as beauticians). Depending on the nature of the product, application of products could be
by hand or through the use of an applicator.
CATEGORY OF WORKERS
EXPOSURE DETAILS
Transport and storage
Transport and storage workers may come into contact with the notified polymer either at < 10% concentration as
a component of Uvinul Easy or at < 5% concentration as a component of finished cosmetic products, only in the
event of accidental rupture of containers.
End-use
Exposure to the notified polymer in end-use products may occur in professions where the services provided
involve the application of cosmetic products (at < 5% concentration) to clients (e.g. workers in beauty salons).
The principal route of exposure will be dermal, while ocular exposure is also possible. Good hygiene practices
are expected to be in place. Exposure of such workers is expected to be of a similar or lesser extent than that
experienced by consumers using products containing the notified polymer.
Data on typical use patterns of cosmetic product categories in which the notified polymer may be used are shown
in the following table (SCCS, 2012). For the purposes of the exposure assessment via the dermal route,
Australian use patterns for the various product categories are assumed to be similar to those in Europe. A dermal
absorption of 10% was assumed for the notified polymer based on dermal absorption studies on an analogue (see
Section 6.2, Toxicokinetics). An adult bodyweight of 64 kg was used for calculation purposes.
The worst case scenario estimation using these assumptions is for a person who is a simultaneous user of all
products listed in the above table that contain the notified polymer. This would result in a combined internal
dose of 0.7792 mg/kg bw/day.
Toxicokinetics
No data on the toxicokinetics of the notified polymer was provided. The notified polymer is an ionic surfactant
with a moderately high molecular weight (NAMW > 500 Da); therefore dermal absorption is expected to be
limited. This is supported by the low skin penetration (< 2%) observed for Laureth-6 (C12AE6) in a dermal
penetration study on two human volunteers using radiolabelling (HERA, 2009). Laureth-6 is considered
acceptable to estimate the dermal absorption of the notified polymer as it is of lower molecular weight and has a
similar structure but without the ionic functionality present in the notified polymer which is expected to further
limit absorption. While there is uncertainty about the dermal absorption potential of the notified polymer, a value
of 10% dermal absorption was assumed for quantitative risk assessment purposes. Given the surfactant
properties of the notified polymer it may enhance the dermal absorption of other chemicals.
The notified polymer is expected to hydrolyse in the stomach to citric acid and AEs (C12AE7 on average). Oral
absorption studies on AEs found that these chemicals were absorbed in the GI tract and extensively and rapidly
excreted in the urine. A small amount was excreted in faeces and expired air (as CO2) (HERA, 2009). Orally
administered citric acid is largely absorbed and metabolised, and is an intermediate in the Krebs cycle (CIR.
2012).
Acute toxicity
Acute toxicity data on the notified polymer was not provided.
A study on an AE similar to that used for the manufacture of the notified polymer (i.e. C12AE7 on average) in
rats indicated low to moderate acute oral toxicity. An apparent sex difference was observed in the study; with
females being more susceptible to the acute oral toxicity (LD50: 500 to 2000 mg/kg) than males (LD50: > 2000
mg/kg). However it has been suggested that this is not a sex specific phenomenon, but an effect related to body
weight; lighter animals being more susceptible than heavier animals (HERA 2009).
In general AEs have been shown to be of low to moderate acute oral toxicity, and of low acute dermal and
inhalation toxicity (HERA 2009). For acute oral toxicity there is an apparent relationship with the degree of
ethoxylation of the AE, with ethoxylate chains between 5 and 14 being more toxic than those with less than 4 or
more than 21 ethoxy units. The notified polymer has on average 7 ethoxy units. Therefore, based on the available
information, the notified polymer may be harmful by the oral route.
A human repeated insult patch test using the notified polymer at 10% concentration did not reveal any signs of
irritation or sensitisation.
AEs with varying carbon chain lengths and degree of ethoxylation were found to be slightly to severely irritating
to skin and eye in rabbits and rats (HERA 2009). Therefore, in the absence of skin and eye irritation data for
undiluted notified polymer, potential skin and eye irritation effects of the notified polymer cannot be ruled out on
the basis of data for AEs (HERA 2009)
A number of AEs have been evaluated in oral and dermal repeated dose toxicity studies. The NOAEL of AEs for
systemic toxicity was established to be 50 mg/kg bw/day on the basis of a scientifically sound and well
conducted 2-year oral feeding study in rats with C12-13AE6.5 (HERA, 2009). Effects observed at the LOAEL were
related to significantly elevated organ-to-body weight ratios for liver, kidney and heart. No adverse
histopathological changes were observed at the LOAEL. This NOAEL is consistent with the outcome of the
majority of existing chronic and subchronic studies determined for AEs. Only one 90-day study revealed some
minor effects at a dose level of 50 mg/kg bw/day which were not considered be of toxicological significance.
A NOAEL of 50 mg/kg bw/day is therefore considered for the notified polymer for quantitative risk assessment
purposes.
Mutagenicity/Genotoxicity
The notified polymer was negative in a bacterial reverse mutation study. No further genotoxicity data is available
for the notified polymer.
Based on a number of in vitro and in vivo studies, there is no evidence that AEs are either mutagenic or
genotoxic (HERA, 2009).
Therefore, based on the available information, the notified polymer is not expected to be genotoxic.
Reformulation
Reformulation workers may be exposed to the notified polymer at < 10% concentration. However at the
proposed use concentration acute toxicity effects are not expected. Furthermore, the proposed use of PPE and
enclosed, automated processes should minimise the potential for exposure.
End-use
Workers involved in professions where the services provided involve the application of cosmetic products
containing the notified polymer to clients (e.g., hairdressers and beauty salon workers) may be exposed to the
notified polymer at < 5% concentration. The risk to these workers is expected to be of similar or lesser extent
than that experienced by consumers using products containing the notified polymer. Such professionals may use
PPE (i.e, gloves and glasses) to minimise repeated exposure, and good general hygiene measures are expected
to be in place to minimise the potential for exposure.
Overall, based on the information available, the risk to workers associated with use of the notified polymer is
not considered to be unreasonable.
The potential systemic exposure to the public from the use of the notified polymer in cosmetic products was
estimated to be 0.7792 mg/kg bw/day based on a dermal absorption of 10%. Using a NOAEL of 50 mg/kg
bw/day based on a 2-year oral feeding study with an analogue, the margin of exposure (MOE) was estimated to
be 64. A MOE value greater than or equal to 100 is considered acceptable to account for intra- and inter-species
differences. However, given a dermal absorption of 2% has been determined in a dermal absorption study for an
acceptable analogue, a dermal absorption of 10% for the notified polymer is likely to represent a conservative
value. Using a dermal absorption of 2%, the MOE was estimated to be 320.
As the notified polymer may have the potential to enhance dermal absorption of other chemicals due to its
surfactant activity, care should be taken in formulating end-use products containing it.
Based on the available information, the risk to the public associated with the proposed use of the notified
polymer in cosmetic products at < 5% concentration is not considered to be unreasonable.
7. ENVIRONMENTAL IMPLICATIONS
The reformulation process will involve blending operations that will be highly automated, and is expected to
occur within a fully enclosed environment. Therefore, significant release of the notified polymer from this
process to the environment is not expected. The process will be followed by automated filling of the formulated
products into end-use containers of various sizes suitable for retail. Wastes containing the notified polymer
generated during reformulation include equipment wash water, empty import containers, and spilt materials.
Wastes may be collected and released to sewers in a worst case scenario, or disposed of to landfill in accordance
with local government regulations.
container and be disposed of to landfill, or to be released to sewer when containers are rinsed before recycling
through an approved waste management facility.
The majority of the notified polymer will be released to sewer after use. A small proportion of the notified
polymer may be applied to land when effluent is used for irrigation, or when sewage sludge is used for soil
remediation. The notified polymer may also be disposed of to landfill as collected spills and empty container
residue. Residues of the notified polymer in landfill, soil and sludge are expected to eventually degrade through
biotic and abiotic processes to form water and oxides of carbon.
STP effluent re-use for irrigation occurs throughout Australia. The agricultural irrigation application rate is
assumed to be 1,000 L/m2/year (10 ML/ha/year). The notified polymer in this volume is assumed to infiltrate and
accumulate in the top 10 cm of soil (density 1,500 kg/m3). Using these assumptions, irrigation with a
concentration of 1.21 µg/L may potentially result in a soil concentration of approximately 8.08 µg/kg. Assuming
accumulation of the notified polymer in soil for 5 and 10 years under repeated irrigation, the concentration of the
notified polymer in the applied soil in 5 and 10 years may be approximately 40.39 µg/kg and 80.77 µg/kg,
respectively.
Based on the above ecotoxicological endpoints for the notified polymer, it is expected to be acutely harmful to
algae. Therefore, under the Globally Harmonised System of Classification and Labelling of Chemicals (GHS)
(United Nations, 2009) the notified polymer is formally classified as “Acute Category 3; Harmful to aquatic
life”. Based on the above acute toxicity, ready biodegradability and low bioaccumulation potential of the notified
polymer, it is not formally classified under the GHS for chronic toxicity.
The risk quotient for discharge of treated effluents containing the notified polymer to the aquatic environment
indicates that the notified polymer is unlikely to reach ecotoxicologically significant concentrations in surface
waters, based on its maximum annual importation quantity. The notified polymer is readily biodegradable, and is
not expected to be bioaccumulative. On the basis of the PEC/PNEC ratio, maximum annual importation volume
and assessed use pattern in cosmetic products, the notified polymer is not expected to pose an unreasonable risk
to the environment.
RESULTS
RESULTS
Remarks - Results The notified polymer did not exhibit eye irritation potential under the
conditions of the test.
CONCLUSION According to the classification criteria provided in the study report, the
test substance is none to slightly irritating.
RESULTS
Remarks - Results Thirteen (13) subjects discontinued participation for non-test substance
related reasons. There was no evidence of irritation during the study in any
test subject.
CONCLUSION The test substance was non-sensitising and non-irritating under the
conditions of the test.
RESULTS
Remarks - Results No toxicity or precipitation was observed in the mutation tests. The test
substance did not cause a marked increase in the number of revertants per
plate of any of the tester strains either in the presence or absence of S9.
Negative controls were within historical limits. Positive controls
confirmed the sensitivity of the test system.
CONCLUSION The notified polymer was not mutagenic to bacteria under the conditions
of the test.
RESULTS
Remarks - Results All validity criteria for the test were satisfied. The percentage degradation
of the reference compound surpassed the threshold level of 60% by 4 days
(≥ 60.2%). Therefore, the tests indicate the suitability of the inoculums.
The degree of degradation of the test substance after 28 days was 61.1%.
As the test substance is surface active, the 10-day window is not applicable.
Therefore, the test substance is considered to be readily biodegradable
according to the OECD (301 F) guideline.
RESULTS
46 77.7 46 > 85
60 87.4 60 90
*
Second addition of test substance for second incubation
Remarks – Results All validity criteria for the test were satisfied. The percentage degradation
of the reference compound surpassed the threshold level of 60% by 2 days
(75%) and achieved a degradation plateau. Therefore, the tests indicate the
suitability of the inoculums.
The degree of degradation of the test substance after 28 days was > 80%.
Therefore, the test substance is considered to be anaerobically
biodegradable according to the OECD (311) guideline.
RESULTS
Biomass Growth
EbC50 NOEbC ErC50 NOErC
mg/L at 72 h mg/L mg/L at 72 h mg/L
22 4.1 57 8.7
Remarks - Results All validity criteria for the test were satisfied. The test solutions were not
renewed during the 72 h test period. The actual concentrations of the test
substance were measured at the start and end of the 72 h test period. The
72 h EbC50 and ErC50 were determined to be 22 mg/L and 57 mg/L,
respectively, based on nominal concentrations.
BIBLIOGRAPHY
Consumer Product Testing (2003) Repeated Insult Patch Test Protocol No.: 1.01 (Study No. C03-0386.01,
August, 2003). New Jersey, USA, Consumer Product Testing Co. (Unpublished report submitted by the
notifier).
Henkel (1992) [Analogue] Acute Oral Toxicity in Rats (Study No. PT 920008, April, 1992). Düsseldorf,
Germany, Henkel KGaA (Unpublished report submitted by the notifier).
Henkel (2002) In-vitro-test: HET-CAM [HCl] Reaction Time Method (Report No. R 0200073, January, 2002).
Düsseldorf, Germany, Henkel KGaA (Unpublished report submitted by the notifier).
HERA (2009) Alcohol Ethoxylates. Human & Environmental Risk Assessment on ingredients of European
household cleaning products. V.2.0. http://www.heraproject.com/files/34-f-
09%20hera%20ae%20report%20version%202%20-%203%20sept%2009.pdf (Last accessed June 2016).
Hydrotox (2003) Biodegradability in the Manometric Respirometry Test According to OECD 301 F (Study No.
150; August, 2003). Freiburg, Germany, Hydrotox GmbH (Unpublished report submitted by the notifier).
Institut Fresenius (2004) Study on the Toxicity Towards Algae of [Notified polymer] According to OECD-Test
Guideline 201 (Study No. IF-01/00166107, July, 2004). Taunusstein, Germany, Institut Fresenius
(Unpublished report submitted by the notifier).
Landeshauptstadt Düsseldorf (2015) Anaerobic Degradability Under Sewage Plant Simulation Conditions
(AnBUSDiC Test) (Study No. P-1500457, January, 2015). Düsseldorf, Germany, Landeshauptstadt
Düsseldorf (Unpublished report submitted by the notifier).
NOHSC (2004) Approved Criteria for Classifying Hazardous Substances, 3rd edition [NOHSC:1008(2004)].
National Occupational Health and Safety Commission, Canberra, AusInfo.
RCC (2003) Salmonella Typhimurium Reverse Mutation Assay with [Notified polymer] (May, 2003, Study No.
782500). Rossdorf, Germany, RCC Cytotest Cell Research Gmbh (Unpublished report submitted by the
notifier).
SCCS (2012) The SCCS’ Notes of Guidance for the Testing of Cosmetic Substances and their Safety Evaluation
(8th revision) European Commission – Scientific Committee on Consumer Safety.
United Nations (2009) Globally Harmonised System of Classification and Labelling of Chemicals (GHS), 3rd
revised edition. United Nations Economic Commission for Europe (UN/ECE),
<http://www.unece.org/trans/danger/publi/ghs/ghs_rev03/03files_e.html >.